Key Development Dong Nai-2 Hospital has officially announced a comprehensive clinical optimization strategy anchored on long-term partnerships with leading medical... Read more
Tag: #Vietnam
Multi-Site Tertiary Care Models: Analyzing Bach Mai Hospital’s New Satellite Operations and Market Reconfiguration
Key Development The Ninh Binh facility of Bach Mai Hospital has officially commenced clinical operations, marking a major milestone in... Read more
Grassroots Healthcare Decentralization: Da Nang’s Strategic Shift to Commune-Level Management
Key Development Da Nang has officially announced the transfer of 93 health stations and 194 sub-stations, along with preventive health... Read more
Boardroom Restructuring at Imexpharm: Strategic Transitions Following Livzon’s Mega M&A
Key Development Imexpharm Pharmaceutical Joint Stock Company (Ticker: IMP) has officially announced significant leadership modifications within its Board of Directors... Read more
Globalizing Vietnam’s Pharmaceutical Sector: Strategic Levers from WHO’s NRA Alignment
Key Development Vietnam's National Regulatory Authority (NRA) for medicines and vaccines successfully concluded a comprehensive evaluation by the World Health... Read more
Pharmaceutical Supply Chain Optimization: Strategic Infrastructure Shifts of MNCs in Vietnam
Key Development The Vietnamese pharmaceutical market recently witnessed a significant infrastructure realignment as the Ministry of Health approved the voluntary... Read more
The nearly VND 5 trillion Bach Mai Hospital branch in Ninh Binh to launch operations on June 26
On June 26, 2026, the Ninh Binh branch of Bach Mai Hospital—a landmark national healthcare project drawing an aggregate investment... Read more
The Drug Administration of Vietnam proposes revoking 286 cosmetic registration numbers including LEMONADE, Focallure, Johnson’s, and Neutrogena
The Drug Administration of Vietnam (DAV), under the Ministry of Health, has officially drafted an administrative decree to revoke 286... Read more
Carl Zeiss hosts seminar series: Advancing myopia progression management via a high-tech ophthalmic ecosystem
German optical technology leader Carl Zeiss has officially launched a specialized symposium series titled "The Future of Myopia Progression Management... Read more








